TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs35612982
log Bayes Factor = 22.6464
Chromosome 6   position 20,682,622  (GRCh37) Explore rs35612982 on Ensembl!
Variant rs35612982 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E11.9 Without complications
1.000 0.000 0.000
E11 Non-insulin-dependent diabetes mellitus
1.000 0.000 0.000
E10-E14 Diabetes mellitus
1.000 0.000 0.000
E14.9 Without complications
1.000 0.000 0.000
E14 Unspecified diabetes mellitus
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.992 0.008 0.000
E11.3 With ophthalmic complications
0.957 0.043 0.000
E10.9 Without complications
0.946 0.054 0.000
E14.3 With ophthalmic complications
0.914 0.086 0.000
E10.3 With ophthalmic complications
0.904 0.096 0.000
E11.6 With other specified complications
0.903 0.097 0.000
E13 Other specified diabetes mellitus
0.903 0.097 0.000
E10.4 With neurological complications
0.892 0.108 0.000
E11.4 With neurological complications
0.844 0.156 0.000
E13.9 Without complications
0.833 0.167 0.000
E11.2 With renal complications
0.819 0.181 0.000
E14.4 With neurological complications
0.754 0.246 0.000
E10.0 With coma
0.745 0.255 0.000
E10.6 With other specified complications
0.745 0.255 0.000
E11.8 With unspecified complications
0.744 0.256 0.000
E14.6 With other specified complications
0.743 0.257 0.000
E14.8 With unspecified complications
0.738 0.262 0.000
E10.2 With renal complications
0.725 0.275 0.000
E11.7 With multiple complications
0.717 0.283 0.000
E12 Malnutrition-related diabetes mellitus
0.717 0.283 0.000
E14.7 With multiple complications
0.717 0.283 0.000
E14.5 With peripheral circulatory complications
0.717 0.283 0.000
E14.2 Withrenal complications
0.717 0.283 0.000
E14.1 With ketoacidosis
0.717 0.283 0.000
E14.0 With coma
0.717 0.283 0.000
E10.8 With unspecified complications
0.714 0.286 0.000
E10.7 With multiple complications
0.711 0.289 0.000
E11.0 With coma
0.696 0.304 0.000
E13.8 With unspecified complications
0.647 0.353 0.000
E13.7 With multiple complications
0.647 0.353 0.000
E13.6 With other specified complications
0.647 0.353 0.000
E13.5 With peripheral circulatory complications
0.647 0.353 0.000
E13.4 With neurological complications
0.647 0.353 0.000
E13.3 With ophthalmic complications
0.647 0.353 0.000
E13.2 With renal complications
0.647 0.353 0.000
E13.1 With ketoacidosis
0.647 0.353 0.000
E13.0 With coma
0.647 0.353 0.000
E10.5 With peripheral circulatory complications
0.640 0.360 0.000
E10.1 With ketoacidosis
0.631 0.369 0.000
E11.5 With peripheral circulatory complications
0.546 0.454 0.000
E12.9 Without complications
0.514 0.486 0.000
E12.8 With unspecified complications
0.514 0.486 0.000
E12.7 With multiple complications
0.514 0.486 0.000
E12.6 With other specified complications
0.514 0.486 0.000
E12.5 With peripheral circulatory complications
0.514 0.486 0.000
E12.4 With neurological complications
0.514 0.486 0.000
E12.3 With ophthalmic complications
0.514 0.486 0.000
E12.2 With renal complications
0.514 0.486 0.000
E12.1 With ketoacidosis
0.514 0.486 0.000
E12.0 With coma
0.514 0.486 0.000
E11.1 With ketoacidosis
0.404 0.595 0.001
Chapter IV Endocrine, nutritional and metabolic diseases
0.099 0.901 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.093 0.907 0.000
E16 Other disorders of pancreatic internal secretion
0.089 0.911 0.000
E16.2 Hypoglycaemia, unspecified
0.087 0.913 0.000
E40-E46 Malnutrition
0.077 0.923 0.000
F20.9 Schizophrenia, unspecified
0.068 0.932 0.000
F20 Schizophrenia
0.067 0.933 0.000
E15 Nondiabetic hypoglycaemic coma
0.067 0.933 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.066 0.934 0.000
E16.1 Other hypoglycaemia
0.065 0.935 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.064 0.936 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.064 0.936 0.000
E16.4 Abnormal secretion of gastrin
0.064 0.936 0.000
E16.3 Increased secretion of glucagon
0.064 0.936 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.064 0.936 0.000
E50-E64 Other nutritional deficiencies
0.063 0.937 0.000
E46 Unspecified protein-energy malnutrition
0.061 0.939 0.000
F20.0 Paranoid schizophrenia
0.061 0.939 0.000
F25 Schizoaffective disorders
0.058 0.942 0.000
F29 Unspecified nonorganic psychosis
0.058 0.942 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.055 0.945 0.000
E45 Retarded development following protein-energy malnutrition
0.055 0.945 0.000
E43 Unspecified severe protein-energy malnutrition
0.055 0.945 0.000
E42 Marasmic kwashiorkor
0.055 0.945 0.000
E41 Nutritional marasmus
0.055 0.945 0.000
E40 Kwashiorkor
0.055 0.945 0.000
F25.9 Schizoaffective disorder, unspecified
0.055 0.945 0.000
E20-E35 Disorders of other endocrine glands
0.051 0.949 0.000
F23 Acute and transient psychotic disorders
0.049 0.951 0.000
E61 Deficiency of other nutrient elements
0.049 0.951 0.000
F20.8 Other schizophrenia
0.048 0.952 0.000
F20.6 Simple schizophrenia
0.048 0.952 0.000
F20.5 Residual schizophrenia
0.048 0.952 0.000
F20.4 Postschizophrenic depression
0.048 0.952 0.000
F20.3 Undifferentiated schizophrenia
0.048 0.952 0.000
F20.2 Catatonic schizophrenia
0.048 0.952 0.000
F20.1 Hebephrenic schizophrenia
0.048 0.952 0.000
F28 Other nonorganic psychotic disorders
0.046 0.954 0.000
F24 Induced delusional disorder
0.046 0.954 0.000
F21 Schizotypal disorder
0.046 0.954 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.045 0.955 0.000
E63 Other nutritional deficiencies
0.045 0.955 0.000
E56 Other vitamin deficiencies
0.045 0.955 0.000
E51 Thiamine deficiency
0.045 0.955 0.000
E50 Vitamin A deficiency
0.045 0.955 0.000
E60 Dietary zinc deficiency
0.045 0.955 0.000
E59 Dietary selenium deficiency
0.045 0.955 0.000
E58 Dietary calcium deficiency
0.045 0.955 0.000
E54 Ascorbic acid deficiency
0.045 0.955 0.000
E52 Niacin deficiency [pellagra]
0.045 0.955 0.000
E55 Vitamin D deficiency
0.045 0.955 0.000
E26 Hyperaldosteronism
0.044 0.955 0.000
F25.1 Schizoaffective disorder, depressive type
0.044 0.956 0.000
F22 Persistent delusional disorders
0.044 0.956 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.042 0.958 0.000
F25.8 Other schizoaffective disorders
0.042 0.958 0.000
F25.2 Schizoaffective disorder, mixed type
0.042 0.958 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.040 0.960 0.000
E26.0 Primary hyperaldosteronism
0.040 0.960 0.000
E44.1 Mild protein-energy malnutrition
0.040 0.960 0.000
E44.0 Moderate protein-energy malnutrition
0.040 0.960 0.000
E27 Other disorders of adrenal gland
0.040 0.960 0.000
E65-E68 Obesity and other hyperalimentation
0.040 0.960 0.000
E24 Cushing's syndrome
0.039 0.961 0.000
E61.1 Iron deficiency
0.039 0.961 0.000
F25.0 Schizoaffective disorder, manic type
0.038 0.962 0.000
E21.0 Primary hyperparathyroidism
0.038 0.962 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.037 0.963 0.000
E32 Diseases of thymus
0.037 0.963 0.000
E31 Polyglandular dysfunction
0.037 0.963 0.000
E30 Disorders of puberty, not elsewhere classified
0.037 0.963 0.000
E25 Adrenogenital disorders
0.037 0.963 0.000
E22 Hyperfunction of pituitary gland
0.036 0.963 0.000
F23.8 Other acute and transient psychotic disorders
0.035 0.964 0.000
F23.3 Other acute predominantly delusional psychotic disorders
0.035 0.964 0.000
F23.2 Acute schizophrenia-like psychotic disorder
0.035 0.964 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.035 0.964 0.000
Chapter V Mental and behavioural disorders
0.035 0.965 0.000
E61.9 Deficiency of nutrient element, unspecified
0.035 0.965 0.000
E61.8 Deficiency of other specified nutrient elements
0.035 0.965 0.000
E61.7 Deficiency of multiple nutrient elements
0.035 0.965 0.000
E61.6 Vanadium deficiency
0.035 0.965 0.000
E61.5 Molybdenum deficiency
0.035 0.965 0.000
E61.4 Chromium deficiency
0.035 0.965 0.000
E61.3 Manganese deficiency
0.035 0.965 0.000
E61.2 Magnesium deficiency
0.035 0.965 0.000
E61.0 Copper deficiency
0.035 0.965 0.000
E21.2 Other hyperparathyroidism
0.035 0.965 0.000
E27.1 Primary adrenocortical insufficiency
0.034 0.965 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.034 0.966 0.000
E20 Hypoparathyroidism
0.034 0.966 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.034 0.966 0.000
E27.8 Other specified disorders of adrenal gland
0.034 0.966 0.000
E50.9 Vitamin A deficiency, unspecified
0.032 0.967 0.000
E50.8 Other manifestations of vitamin A deficiency
0.032 0.967 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.032 0.967 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.032 0.967 0.000
E50.5 Vitamin A deficiency with night blindness
0.032 0.967 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.032 0.967 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.032 0.967 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.032 0.967 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.032 0.967 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.032 0.967 0.000
E51.9 Thiamine deficiency, unspecified
0.032 0.967 0.000
E51.8 Other manifestations of thiamine deficiency
0.032 0.967 0.000
E51.2 Wernicke's encephalopathy
0.032 0.967 0.000
E51.1 Beriberi
0.032 0.967 0.000
E56.9 Vitamin deficiency, unspecified
0.032 0.967 0.000
E56.8 Deficiency of other vitamins
0.032 0.967 0.000
E56.1 Deficiency of vitamin K
0.032 0.967 0.000
E56.0 Deficiency of vitamin E
0.032 0.967 0.000
E63.9 Nutritional deficiency, unspecified
0.032 0.967 0.000
E63.8 Other specified nutritional deficiencies
0.032 0.967 0.000
E63.1 Imbalance of constituents of food intake
0.032 0.967 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.032 0.967 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.032 0.967 0.000
E64.8 Sequelae of other nutritional deficiencies
0.032 0.967 0.000
E64.3 Sequelae of rickets
0.032 0.967 0.000
E64.2 Sequelae of vitamin C deficiency
0.032 0.967 0.000
E64.1 Sequelae of vitamin A deficiency
0.032 0.967 0.000
E64.0 Sequelae of protein-energy malnutrition
0.032 0.967 0.000
F22.9 Persistent delusional disorder, unspecified
0.032 0.967 0.000
E55.0 Rickets, active
0.032 0.968 0.000
E29 Testicular dysfunction
0.032 0.968 0.000
E26.9 Hyperaldosteronism, unspecified
0.032 0.968 0.000
E26.8 Other hyperaldosteronism
0.032 0.968 0.000
E26.1 Secondary hyperaldosteronism
0.032 0.968 0.000
E70-E90 Metabolic disorders
0.032 0.968 0.000
E55.9 Vitamin D deficiency, unspecified
0.032 0.968 0.000
F22.8 Other persistent delusional disorders
0.031 0.968 0.000
E24.2 Drug-induced Cushing's syndrome
0.031 0.968 0.000
E53 Deficiency of other B group vitamins
0.031 0.968 0.000
F60-F69 Disorders of adult personality and behaviour
0.031 0.969 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.030 0.969 0.000
E21.4 Other specified disorders of parathyroid gland
0.030 0.969 0.000
F10.3 Withdrawal state
0.031 0.969 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.030 0.970 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.030 0.970 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.030 0.970 0.000
F80-F89 Disorders of psychological development
0.030 0.970 0.000
E28 Ovarian dysfunction
0.029 0.970 0.000
E88 Other metabolic disorders
0.029 0.971 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.029 0.971 0.000
E27.5 Adrenomedullary hyperfunction
0.029 0.971 0.000
E27.0 Other adrenocortical overactivity
0.029 0.971 0.000
E67 Other hyperalimentation
0.029 0.971 0.000
E68 Sequelae of hyperalimentation
0.029 0.971 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.028 0.972 0.000
E85 Amyloidosis
0.028 0.972 0.000
F22.0 Delusional disorder
0.028 0.972 0.000
E24.8 Other Cushing's syndrome
0.028 0.972 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.028 0.972 0.000
E24.3 Ectopic ACTH syndrome
0.028 0.972 0.000
E24.1 Nelson's syndrome
0.028 0.972 0.000
E24.9 Cushing's syndrome, unspecified
0.028 0.972 0.000
E34 Other endocrine disorders
0.027 0.972 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.027 0.973 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.027 0.973 0.000
E86 Volume depletion
0.027 0.973 0.000
F60 Specific personality disorders
0.027 0.973 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.027 0.973 0.000
F80 Specific developmental disorders of speech and language
0.027 0.973 0.000
E25.9 Adrenogenital disorder, unspecified
0.027 0.973 0.000
E25.8 Other adrenogenital disorders
0.027 0.973 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.027 0.973 0.000
E30.9 Disorder of puberty, unspecified
0.027 0.973 0.000
E30.8 Other disorders of puberty
0.027 0.973 0.000
E30.1 Precocious puberty
0.027 0.973 0.000
E30.0 Delayed puberty
0.027 0.973 0.000
E31.9 Polyglandular dysfunction, unspecified
0.027 0.973 0.000
E31.8 Other polyglandular dysfunction
0.027 0.973 0.000
E31.1 Polyglandular hyperfunction
0.027 0.973 0.000
E31.0 Autoimmune polyglandular failure
0.027 0.973 0.000
E32.9 Disease of thymus, unspecified
0.027 0.973 0.000
E32.8 Other diseases of thymus
0.027 0.973 0.000
E32.1 Abscess of thymus
0.027 0.973 0.000
E32.0 Persistent hyperplasia of thymus
0.027 0.973 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.027 0.973 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.027 0.973 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.027 0.973 0.000
E27.2 Addisonian crisis
0.026 0.973 0.000
F99-F99 Unspecified mental disorder
0.027 0.973 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.026 0.974 0.000
E22.8 Other hyperfunction of pituitary gland
0.026 0.974 0.000
F50 Eating disorders
0.026 0.974 0.000
E24.0 Pituitary-dependent Cushing's disease
0.026 0.974 0.000
F62 Enduring personality changes, not attributable to brain damage and disease
0.026 0.974 0.000
E85.4 Organ-limited amyloidosis
0.026 0.974 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.026 0.974 0.000
F10.0 Acute intoxication
0.026 0.974 0.000
F11 Mental and behavioural disorders due to use of opioids
0.025 0.974 0.000
K50.0 Crohn's disease of small intestine
0.025 0.975 0.000
E65 Localised adiposity
0.025 0.975 0.000
E79 Disorders of purine and pyrimidine metabolism
0.025 0.975 0.000
F80.1 Expressive language disorder
0.025 0.975 0.000
F70-F79 Mental retardation
0.025 0.975 0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease
0.025 0.975 0.000
F69 Unspecified disorder of adult personality and behaviour
0.024 0.975 0.000
E20.8 Other hypoparathyroidism
0.024 0.975 0.000
E20.1 Pseudohypoparathyroidism
0.024 0.975 0.000
E20.0 Idiopathic hypoparathyroidism
0.024 0.975 0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.024 0.976 0.000
E28.3 Primary ovarian failure
0.024 0.976 0.000
E29.9 Testicular dysfunction, unspecified
0.023 0.977 0.000
E29.8 Other testicular dysfunction
0.023 0.977 0.000
E29.0 Testicular hyperfunction
0.023 0.977 0.000
E84 Cystic fibrosis
0.023 0.977 0.000
E77 Disorders of glycoprotein metabolism
0.023 0.977 0.000
E76 Disorders of glycosaminoglycan metabolism
0.023 0.977 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.023 0.977 0.000
E72 Other disorders of amino-acid metabolism
0.023 0.977 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.023 0.977 0.000
E70 Disorders of aromatic amino-acid metabolism
0.023 0.977 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.023 0.977 0.000
E53.1 Pyridoxine deficiency
0.023 0.977 0.000
E53.0 Riboflavin deficiency
0.023 0.977 0.000
F02 Dementia in other diseases classified elsewhere
0.023 0.977 0.000
F68 Other disorders of adult personality and behaviour
0.023 0.977 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.023 0.977 0.000
F65 Disorders of sexual preference
0.023 0.977 0.000
F63 Habit and impulse disorders
0.023 0.977 0.000
F61 Mixed and other personality disorders
0.023 0.977 0.000
F00 Dementia in Alzheimer's disease
0.023 0.977 0.000
E27.9 Disorder of adrenal gland, unspecified
0.022 0.978 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.022 0.978 0.000
F60.9 Personality disorder, unspecified
0.022 0.978 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.022 0.978 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.022 0.978 0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.022 0.978 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.022 0.978 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.022 0.978 0.000
F50.0 Anorexia nervosa
0.022 0.978 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.022 0.978 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.022 0.978 0.000
F51 Nonorganic sleep disorders
0.022 0.978 0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.022 0.978 0.000
F55 Abuse of non-dependence-producing substances
0.022 0.978 0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.022 0.978 0.000
F10.4 Withdrawal state with delirium
0.022 0.978 0.000
F62.9 Enduring personality change, unspecified
0.022 0.978 0.000
F89 Unspecified disorder of psychological development
0.021 0.978 0.000
F88 Other disorders of psychological development
0.021 0.978 0.000
F83 Mixed specific developmental disorders
0.021 0.978 0.000
F82 Specific developmental disorder of motor function
0.021 0.978 0.000
F60.6 Anxious [avoidant] personality disorder
0.021 0.978 0.000
E28.9 Ovarian dysfunction, unspecified
0.021 0.979 0.000
E28.8 Other ovarian dysfunction
0.021 0.979 0.000
E28.1 Androgen excess
0.021 0.979 0.000
E28.0 Oestrogen excess
0.021 0.979 0.000
E20.9 Hypoparathyroidism, unspecified
0.021 0.979 0.000
F10.5 Psychotic disorder
0.021 0.979 0.000
F84 Pervasive developmental disorders
0.021 0.979 0.000
E53.9 Vitamin B deficiency, unspecified
0.021 0.979 0.000
F50.9 Eating disorder, unspecified
0.021 0.979 0.000
E88.9 Metabolic disorder, unspecified
0.021 0.979 0.000
E88.3 Tumour lysis syndrome
0.021 0.979 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.021 0.979 0.000
F06.7 Mild cognitive disorder
0.021 0.979 0.000
E67.8 Other specified hyperalimentation
0.021 0.979 0.000
E67.3 Hypervitaminosis D
0.021 0.979 0.000
E67.2 Megavitamin-B6 syndrome
0.021 0.979 0.000
E67.1 Hypercarotenaemia
0.021 0.979 0.000
E67.0 Hypervitaminosis A
0.021 0.979 0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease
0.021 0.979 0.000
F60.7 Dependent personality disorder
0.021 0.979 0.000
K50 Crohn's disease [regional enteritis]
0.021 0.979 0.000
E85.3 Secondary systemic amyloidosis
0.021 0.979 0.000
F10.8 Other mental and behavioural disorders
0.021 0.979 0.000
F10.7 Residual and late-onset psychotic disorder
0.021 0.979 0.000
F11.2 Dependence syndrome
0.020 0.979 0.000
E85.9 Amyloidosis, unspecified
0.020 0.979 0.000
E85.8 Other amyloidosis
0.020 0.979 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.020 0.979 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.020 0.979 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.020 0.979 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.020 0.979 0.000
E88.8 Other specified metabolic disorders
0.020 0.980 0.000
F60.8 Other specific personality disorders
0.020 0.980 0.000
F99 Mental disorder, not otherwise specified
0.020 0.980 0.000
E34.5 Androgen resistance syndrome
0.020 0.980 0.000
E34.4 Constitutional tall stature
0.020 0.980 0.000
E34.3 Short stature, not elsewhere classified
0.020 0.980 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.020 0.980 0.000
E34.1 Other hypersecretion of intestinal hormones
0.020 0.980 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.020 0.980 0.000
E21.3 Hyperparathyroidism, unspecified
0.020 0.980 0.000
F60.3 Emotionally unstable personality disorder
0.020 0.980 0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction
0.020 0.980 0.000
F09 Unspecified organic or symptomatic mental disorder
0.020 0.980 0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
0.020 0.980 0.000
F11.1 Harmful use
0.020 0.980 0.000
F50.2 Bulimia nervosa
0.020 0.980 0.000
F64 Gender identity disorders
0.020 0.980 0.000
E74 Other disorders of carbohydrate metabolism
0.020 0.980 0.000
F60.4 Histrionic personality disorder
0.020 0.980 0.000
F60.2 Dissocial personality disorder
0.020 0.980 0.000
F60.1 Schizoid personality disorder
0.020 0.980 0.000
F60.0 Paranoid personality disorder
0.020 0.980 0.000
F80.9 Developmental disorder of speech and language, unspecified
0.019 0.980 0.000
F80.8 Other developmental disorders of speech and language
0.019 0.980 0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]
0.019 0.980 0.000
F80.2 Receptive language disorder
0.019 0.980 0.000
F80.0 Specific speech articulation disorder
0.019 0.980 0.000
F10.6 Amnesic syndrome
0.019 0.980 0.000
F00.9 Dementia in Alzheimer's disease, unspecified
0.019 0.981 0.000
E73 Lactose intolerance
0.019 0.981 0.000
K50.1 Crohn's disease of large intestine
0.019 0.981 0.000
F11.3 Withdrawal state
0.019 0.981 0.000
F50.8 Other eating disorders
0.019 0.981 0.000
F50.5 Vomiting associated with other psychological disturbances
0.019 0.981 0.000
F50.4 Overeating associated with other psychological disturbances
0.019 0.981 0.000
F50.3 Atypical bulimia nervosa
0.019 0.981 0.000
F50.1 Atypical anorexia nervosa
0.019 0.981 0.000
F81 Specific developmental disorders of scholastic skills
0.019 0.981 0.000
F19.2 Dependence syndrome
0.019 0.981 0.000
E22.0 Acromegaly and pituitary gigantism
0.019 0.981 0.000
F02.0 Dementia in Pick's disease
0.019 0.981 0.000
F60.5 Anankastic personality disorder
0.019 0.981 0.000
F62.8 Other enduring personality changes
0.019 0.981 0.000
F62.1 Enduring personality change after psychiatric illness
0.019 0.981 0.000
F62.0 Enduring personality change after catastrophic experience
0.019 0.981 0.000
E29.1 Testicular hypofunction
0.019 0.981 0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.018 0.981 0.000
F95 Tic disorders
0.018 0.981 0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence
0.018 0.981 0.000
F93 Emotional disorders with onset specific to childhood
0.018 0.981 0.000
F92 Mixed disorders of conduct and emotions
0.018 0.981 0.000
F91 Conduct disorders
0.018 0.981 0.000
F90 Hyperkinetic disorders
0.018 0.981 0.000
F11.9 Unspecified mental and behavioural disorder
0.018 0.981 0.000
F11.8 Other mental and behavioural disorders
0.018 0.981 0.000
F11.7 Residual and late-onset psychotic disorder
0.018 0.981 0.000
F11.6 Amnesic syndrome
0.018 0.981 0.000
F11.5 Psychotic disorder
0.018 0.981 0.000
F11.4 Withdrawal state with delirium
0.018 0.981 0.000
F11.0 Acute intoxication
0.018 0.981 0.000
K50.9 Crohn's disease, unspecified
0.019 0.981 0.000
F01 Vascular dementia
0.018 0.981 0.000
E34.9 Endocrine disorder, unspecified
0.018 0.982 0.000
F10.9 Unspecified mental and behavioural disorder
0.018 0.982 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.018 0.982 0.000
E79.8 Other disorders of purine and pyrimidine metabolism
0.018 0.982 0.000
E79.1 Lesch-Nyhan syndrome
0.018 0.982 0.000
F19.1 Harmful use
0.018 0.982 0.000
F78 Other mental retardation
0.018 0.982 0.000
F73 Profound mental retardation
0.018 0.982 0.000
F72 Severe mental retardation
0.018 0.982 0.000
F71 Moderate mental retardation
0.018 0.982 0.000
F70 Mild mental retardation
0.018 0.982 0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease
0.018 0.982 0.000
F06.6 Organic emotionally labile [asthenic] disorder
0.018 0.982 0.000
F06.5 Organic dissociative disorder
0.018 0.982 0.000
F06.4 Organic anxiety disorder
0.018 0.982 0.000
F06.3 Organic mood [affective] disorders
0.018 0.982 0.000
F06.2 Organic delusional [schizophrenia-like] disorder
0.018 0.982 0.000
F06.1 Organic catatonic disorder
0.018 0.982 0.000
F06.0 Organic hallucinosis
0.018 0.982 0.000
E34.0 Carcinoid syndrome
0.017 0.982 0.000
E22.1 Hyperprolactinaemia
0.017 0.982 0.000
F19.9 Unspecified mental and behavioural disorder
0.017 0.982 0.000
F19.8 Other mental and behavioural disorders
0.017 0.982 0.000
F19.7 Residual and late-onset psychotic disorder
0.017 0.982 0.000
F19.6 Amnesic syndrome
0.017 0.982 0.000
F19.5 Psychotic disorder
0.017 0.982 0.000
F19.4 Withdrawal state with delirium
0.017 0.982 0.000
F19.3 Withdrawal state
0.017 0.982 0.000
F19.0 Acute intoxication
0.017 0.982 0.000
F02.3 Dementia in Parkinson's disease
0.017 0.983 0.000
F79 Unspecified mental retardation
0.017 0.983 0.000
F52.0 Lack or loss of sexual desire
0.017 0.983 0.000
F02.8 Dementia in other specified diseases classified elsewhere
0.017 0.983 0.000
E34.8 Other specified endocrine disorders
0.017 0.983 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.017 0.983 0.000
E70.8 Other disorders of aromatic amino-acid metabolism
0.017 0.983 0.000
E70.3 Albinism
0.017 0.983 0.000
E70.2 Disorders of tyrosine metabolism
0.017 0.983 0.000
E70.1 Other hyperphenylalaninaemias
0.017 0.983 0.000
E70.0 Classical phenylketonuria
0.017 0.983 0.000
E71.3 Disorders of fatty-acid metabolism
0.017 0.983 0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.017 0.983 0.000
E71.1 Other disorders of branched-chain amino-acid metabolism
0.017 0.983 0.000
E71.0 Maple-syrup-urine disease
0.017 0.983 0.000
E72.9 Disorder of amino-acid metabolism, unspecified
0.017 0.983 0.000
E72.8 Other specified disorders of amino-acid metabolism
0.017 0.983 0.000
E72.5 Disorders of glycine metabolism
0.017 0.983 0.000
E72.4 Disorders of ornithine metabolism
0.017 0.983 0.000
E72.3 Disorders of lysine and hydroxylysine metabolism
0.017 0.983 0.000
E72.2 Disorders of urea cycle metabolism
0.017 0.983 0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.017 0.983 0.000
E72.0 Disorders of amino-acid transport
0.017 0.983 0.000
E75.6 Lipid storage disorder, unspecified
0.017 0.983 0.000
E75.5 Other lipid storage disorders
0.017 0.983 0.000
E75.4 Neuronal ceroid lipofuscinosis
0.017 0.983 0.000
E75.3 Sphingolipidosis, unspecified
0.017 0.983 0.000
E75.2 Other sphingolipidosis
0.017 0.983 0.000
E75.1 Other gangliosidosis
0.017 0.983 0.000
E75.0 GM2 gangliosidosis
0.017 0.983 0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.017 0.983 0.000
E76.8 Other disorders of glucosaminoglycan metabolism
0.017 0.983 0.000
E76.3 Mucopolysaccharidosis, unspecified
0.017 0.983 0.000
E76.2 Other mucopolysaccharidoses
0.017 0.983 0.000
E76.1 Mucopolysaccharidosis, type II
0.017 0.983 0.000
E76.0 Mucopolysaccharidosis, type I
0.017 0.983 0.000
E77.9 Disorder of glycoprotein metabolism, unspecified
0.017 0.983 0.000
E77.8 Other disorders of glycoprotein metabolism
0.017 0.983 0.000
E77.1 Defects in glycoprotein degradation
0.017 0.983 0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.017 0.983 0.000
E80.2 Other porphyria
0.017 0.983 0.000
E84.9 Cystic fibrosis, unspecified
0.017 0.983 0.000
E84.8 Cystic fibrosis with other manifestations
0.017 0.983 0.000
E84.1 Cystic fibrosis with intestinal manifestations
0.017 0.983 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.017 0.983 0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease
0.016 0.983 0.000
F02.2 Dementia in Huntington's disease
0.016 0.983 0.000
F02.1 Dementia in Creutzfeldt-Jakob disease
0.016 0.983 0.000
F63.9 Habit and impulse disorder, unspecified
0.016 0.983 0.000
F63.8 Other habit and impulse disorders
0.016 0.983 0.000
F63.3 Trichotillomania
0.016 0.983 0.000
F63.2 Pathological stealing [kleptomania]
0.016 0.983 0.000
F63.1 Pathological fire-setting [pyromania]
0.016 0.983 0.000
F63.0 Pathological gambling
0.016 0.983 0.000
F65.9 Disorder of sexual preference, unspecified
0.016 0.983 0.000
F65.8 Other disorders of sexual preference
0.016 0.983 0.000
F65.6 Multiple disorders of sexual preference
0.016 0.983 0.000
F65.5 Sadomasochism
0.016 0.983 0.000
F65.4 Paedophilia
0.016 0.983 0.000
F65.3 Voyeurism
0.016 0.983 0.000
F65.2 Exhibitionism
0.016 0.983 0.000
F65.1 Fetishistic transvestism
0.016 0.983 0.000
F65.0 Fetishism
0.016 0.983 0.000
F66.9 Psychosexual development disorder, unspecified
0.016 0.983 0.000
F66.8 Other psychosexual development disorders
0.016 0.983 0.000
F66.2 Sexual relationship disorder
0.016 0.983 0.000
F66.1 Egodystonic sexual orientation
0.016 0.983 0.000
F66.0 Sexual maturation disorder
0.016 0.983 0.000
F68.8 Other specified disorders of adult personality and behaviour
0.016 0.983 0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]
0.016 0.983 0.000
F68.0 Elaboration of physical symptoms for psychological reasons
0.016 0.983 0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type
0.016 0.983 0.000
F00.1 Dementia in Alzheimer's disease with late onset
0.016 0.983 0.000
F00.0 Dementia in Alzheimer's disease with early onset
0.016 0.984 0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease
0.016 0.984 0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease
0.016 0.984 0.000
F52.7 Excessive sexual drive
0.016 0.984 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.